Scientists identify genes implicated in the high regenerative capacity of embryos and ESCs

January 16, 2018, Biogerontology Research Foundation

Researchers at Insilico Medicine, AgeX Therapeutics and the Biogerontology Research Foundation have published a landmark study titled "Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells" in the journal Oncotarget.

In the study, researchers used deep learning techniques to analyze gene expression data in embryonic stem cell (ESC) lines at varying stages of development in order to characterize the of cells right at the boundary of the embryonic-fetal transition, when embryos become fetuses and experience a remarkable reduction in their . In essence, the study's objective was to hone in on those responsible for the remarkable regenerative capacities of embryos and ESCs.

Mimicking the gene expression profile of cells prior to the embryonic fetal transition in adult tissues and organs is the concept underlying one of the central and most ambitious therapeutic modalities being pursued by AgeX Therapeutics, namely induced Tissue Regeneration (iTR). Therapeutic elaboration of the insights derived from this study could pave the way for in-situ tissue regeneration, and its application to ageing and age-related disease.

"induced Tissue Regeneration (iTR) is one of the most promising therapeutic modalities for enabling in-situ proposed to date, and one that is likely to bring substantial healthspan-extending effects if implemented. This landmark study paves the way toward that bright future. Interestingly, in its identification of COX7A1 as one of the genes implicated in the remarkable regenerative potential of embryos and ESCs, the study also extends the purview of these findings to novel potential cancer therapies as well" said Franco Cortese, Deputy Director of the Biogerontology Research Foundation.

The authors also developed effective methods of deriving biologically-relevant information from these profiles, identifying the most interesting genes characterizing the regenerative capacity of ESCs, and performed additional experimental validation to support the findings of the study's deep learning analysis. Interestingly, one of the genes implicated in the embryonic-fetal transition that the study identified, COX7A1, is dysregulated in a diverse array of cancer types, including breast, lung, kidney, bone and muscle. As such, the results of this study could be used create novel cancer therapies as well.

"AI is quickly becoming the main driver of progress in so many fields of science, technology and human endeavor that it is easy for one to lose count. From healthcare to finance to governance, AI is galvanizing rapid paradigm shifts all around us. Insilico Medicine is rapidly establishing themselves as the leader of AI for longevity, and the combination of their deep-learning expertise with the assets for expert experimental validation and interpretation possessed by AgeX Therapeutics is a partnership that has yielded significant synergistic results in using AI to yield novel insights into the biology of aging and charting the path toward next generation healthspan-extending therapies" said Dmitry Kaminskiy, Managing Trustee of the Biogerontology Research Foundation.

Explore further: Scientists find natural mimetics of anti-cancer, anti-aging drugs metformin and rapamycin

More information: Michael D. West et al. Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells, Oncotarget (2017). DOI: 10.18632/oncotarget.23748

Related Stories

Scientists find natural mimetics of anti-cancer, anti-aging drugs metformin and rapamycin

November 29, 2017
Researchers from the Biogerontology Research Foundation, Insilico Medicine, Life Extension and other institutions have published a study in the journal Aging on the identification of natural mimetics of metformin and rapamycin. ...

Induced Cell Turnover: A proposed modality for in situ tissue regeneration & repair

June 15, 2017
Thursday, July 15, 2017, London, UK: Scientists at the Biogerontology Research Foundation, Feinberg School of Medicine at Northwestern University and Swammerdam Institute of Life Sciences at the University of Amsterdam have ...

Elucidation of bone regeneration mechanism

November 3, 2017
How osteoblasts are supplied during bone regeneration has been controversial among bone researchers. According to Atsushi Kawakami, an Associate Professor who specializes in tissue regeneration and led the study, scientists ...

Benchmark database of lifespan-extending drugs announced

March 14, 2017
Scientists from the Biogerontology Research Foundation (BGRF) and University of Liverpool have announced a landmark database of lifespan-extending drugs and compounds called DrugAge. The database has 418 compounds, curated ...

Recommended for you

Robots grow mini-organs from human stem cells

May 17, 2018
An automated system that uses robots has been designed to rapidly produce human mini-organs derived from stem cells. Researchers at the University of Washington School of Medicine in Seattle developed the new system.

Scientists uncover a new face of a famous protein, SWI2/SNF2 ATPase

May 17, 2018
A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression ...

Antibacterial in your toothpaste may combat severe lung disease

May 17, 2018
A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, or CF, when combined with an already FDA-approved drug.

Blocking two enzymes could make cancer cells mortal

May 17, 2018
EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening. Blocking them might be a new anticancer strategy for stopping telomerase, the enzyme that immortalizes tumors.

Emergency contact information helps researchers branch out family tree

May 17, 2018
When you go to the doctor or hospital, one piece of information that you're always asked to provide—in addition to your name, address, and insurance information—is an emergency contact. Often, that person is a blood relative. ...

Study identifies bacterial gene responsible for producing enzyme that consumes cardiac drug

May 17, 2018
Though digoxin has been widely prescribed for decades to treat a variety of heart conditions, doctors have also long understood that, for some patients, the drug simply doesn't work.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.